Upregulated IL-7 receptor a expression on colitogenic memory CD4 + T cells may participate in the development and persistence of chronic colitis

Journal of Immunology

Volumn 186, Issue 4, 2011, Pages 2623-2632

  Shinohara, Tamako ^a   Nemoto, Yasuhiro ^a   Kanai, Takanori ^b   Kameyama, Kaori ^a   Okamoto, Ryuichi ^a   Tsuchiya, Kiichiro ^a   Nakamura, Tetsuya ^a   Totsuka, Teruji ^a   Ikuta, Koichi ^c   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HERMES ANTIGEN; INTERLEUKIN 7 RECEPTOR ALPHA; RAG2 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; COLITIS; CONTROLLED STUDY; DONOR; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; HYPOTHESIS; IMMUNOCOMPETENT CELL; LAMINA PROPRIA; MEMORY T LYMPHOCYTE; MOUSE; MYELOID DENDRITIC CELL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SURVIVAL; UPREGULATION;

ADOPTIVE TRANSFER; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CHRONIC DISEASE; COLITIS; DNA-BINDING PROTEINS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; IMMUNOLOGIC MEMORY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; RECEPTORS, INTERLEUKIN-7; UP-REGULATION;

EID: 79951828164     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000057     Document Type: Article

References (34)

1. Podolsky, D. K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.
2. Sands, B. E. 2007. Inflammatory bowel disease: past, present, and future. J. Gastroenterol. 42: 16-25. (Pubitemid 46351421)
3. Hibi, T., and H. Ogata. 2006. Novel pathophysiological concepts of inflammatory bowel disease. J. Gastroenterol. 41: 10-16.
4. Baumgart, D. C., and W. J. Sandborn. 2007. Inflammatory bowel disease: clinical aspects and established and evolving therapies. Lancet 369: 1641-1657.
5. Duerr, R. H., K. D. Taylor, S. R. Brant, J. D. Rioux, M. S. Silverberg, M. J. Daly, A. H. Steinhart, C. Abraham, M. Regueiro, A. Griffiths, et al. 2006. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-1463. (Pubitemid 44871953)
6. Barrett, J. C., S. Hansoul, D. L. Nicolae, J. H. Cho, R. H. Duerr, J. D. Rioux, S. R. Brant, M. S. Silverberg, K. D. Taylor, M. M. Barmada, et al; NIDDK IBD Genetics Consortium; Belgian-French IBD Consortium; Wellcome Trust Case Control Consortium. 2008. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40: 955-962.
7. + memory T cells causes inflammatory bowel diseases to become intractable. Inflamm. Bowel Dis. 15: 926-934.
8. Namen, A. E., S. Lupton, K. Hjerrild, J.Wignall, D. Y. Mochizuki, A. Schmierer, B. Mosley, C. J. March, D. Urdal, and S. Gillis. 1988. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 333: 571-573.
9. Fry, T. J., and C. L. Mackall. 2005. The many faces of IL-7: from lymphopoiesis to peripheral T cell maintenance. J. Immunol. 174: 6571-6576.
10. Bradley, L. M., L. Haynes, and S. L. Swain. 2005. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 26: 172-176.
11. Kanai, T., Y. Nemoto, N. Kamada, T. Totsuka, T. Hisamatsu, M. Watanabe, and T. Hibi. 2009. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease. Curr. Opin. Gastroenterol. 25: 306-313.
12. Sprent, J., and C. D. Surh. 2002. T cell memory. Annu. Rev. Immunol. 20: 551-579.
13. Schluns, K. S., and L. Lefrançois. 2003. Cytokine control of memory T-cell development and survival. Nat. Rev. Immunol. 3: 269-279.
14. Surh, C. D., and J. Sprent. 2005. Regulation of mature T cell homeostasis. Semin. Immunol. 17: 183-191.
15. Ma, A., R. Koka, and P. Burkett. 2006. Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. Annu. Rev. Immunol. 24: 657-679.
16. Mazzucchelli, R., and S. K. Durum. 2007. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol. 7: 144-154.
17. Palmer, M. J., V. S. Mahajan, L. C. Trajman, D. J. Irvine, D. A. Lauffenburger, and J. Chen. 2008. Interleukin-7 receptor signaling network: an integrated systems perspective. Cell. Mol. Immunol. 5: 79-89.
18. Watanabe, M., Y. Ueno, T. Yajima, Y. Iwao, M. Tsuchiya, H. Ishikawa, S. Aiso, T. Hibi, and H. Ishii. 1995. Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes. J. Clin. Invest. 95: 2945-2953.
19. Watanabe, M., Y. Ueno, T. Yajima, S. Okamoto, T. Hayashi, M. Yamazaki, Y. Iwao, H. Ishii, S. Habu, M. Uehira, et al. 1998. Interleukin 7 transgenic mice develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187: 389-402.
20. + mucosal T cells in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 288: G745-G754.
21. Yamazaki, M., T. Yajima, M. Tanabe, K. Fukui, E. Okada, R. Okamoto, S. Oshima, T. Nakamura, T. Kanai, M. Uehira, et al. 2003. Mucosal T cells expressing high levels of IL-7 receptor are potential targets for treatment of chronic colitis. J. Immunol. 171: 1556-1563. (Pubitemid 36900091)
22. Totsuka, T., T. Kanai, Y. Nemoto, S. Makita, R. Okamoto, K. Tsuchiya, and M. Watanabe. 2007. IL-7 Is essential for the development and the persistence of chronic colitis. J. Immunol. 178: 4737-4748. (Pubitemid 46595254)
23. Maki, K., S. Sunaga, Y. Komagata, Y. Kodaira, A. Mabuchi, H. Karasuyama, K. Yokomuro, J. I. Miyazaki, and K. Ikuta. 1996. Interleukin 7 receptor-deficient mice lack gammadelta T cells. Proc. Natl. Acad. Sci. USA 93: 7172-7177.
24. Totsuka, T., T. Kanai, R. Iiyama, K. Uraushihara, M. Yamazaki, R. Okamoto, T. Hibi, K. Tezuka, M. Azuma, H. Akiba, et al. 2003. Ameliorating effect of anti-ICOS monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124: 410-421. (Pubitemid 36169258)
25. + regulatory T cells is a suppressive site of intestinal inflammation. J. Immunol. 178: 4937-4946.
26. Mikami, Y., T. Kanai, T. Sujino, Y. Ono, A. Hayashi, A. Okazawa, N. Kamada, K. Matsuoka, T. Hisamatsu, S. Okamoto, et al. 2010. Competition between colitogenic Th1 and Th17 cells contributes to the amelioration of colitis. Eur. J. Immunol. 40: 2409-2422.
27. Colonna, M. 2009. Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity. Immunity 31: 15-23.
28. Luci, C., A. Reynders, I. I. Ivanov, C. Cognet, L. Chiche, L. Chasson, J. Hardwigsen, E. Anguiano, J. Banchereau, D. Chaussabel, et al. 2009. Influence of the transcription factor RORgammat on the development of NKp46+ cell populations in gut and skin. Nat. Immunol. 10: 75-82.
29. Vivier, E., H. Spits, and T. Cupedo. 2009. Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair? Nat. Rev. Immunol. 9: 229-234.
30. Peschon, J. J., P. J. Morrissey, K. H. Grabstein, F. J. Ramsdell, E. Maraskovsky, B. C. Gliniak, L. S. Park, S. F. Ziegler, D. E. Williams, C. B. Ware, et al. 1994. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J. Exp. Med. 180: 1955-1960.
31. + T cells. Nat. Immunol. 10: 149-157.
32. Cella, M., A. Fuchs, W. Vermi, F. Facchetti, K. Otero, J. K. Lennerz, J. M. Doherty, J. C. Mills, and M. Colonna. 2009. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725.
33. Zenewicz, L. A., G. D. Yancopoulos, D. M. Valenzuela, A. J. Murphy, S. Stevens, and R. A. Flavell. 2008. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 29: 947-957.
34. Chiang, E. Y., G. A. Kolumam, X. Yu, M. Francesco, S. Ivelja, I. Peng, P. Gribling, J. Shu, W. P. Lee, C. J. Refino, et al. 2009. Targeted depletion of lymphotoxin-alpha-expressing TH1 and TH17 cells inhibits autoimmune disease. Nat. Med. 15: 766-773.